Clinical Trials Logo

Clinical Trial Summary

collaborative work within 2 hospitals at the CHU of Caen, at the CHRU of Lille, concerning the evaluation of the biological markers of primary hyperaldosteronism (PAH) with the dosage of aldosterone in LC -MS/MS, which is performed in both centers, with two different techniques. The main objective is to define the range of Aldosterone concentrations in LC MS/MS, of renin in an automated method, in populations of healthy volunteers, essential hypertensives, and hypertensives with primary hyperaldosteronism. , in order to establish a threshold for the screening of PAH by the RAR, and for the confirmation of PAH by a dynamic test with an Aldosterone threshold post salt load test.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05640128
Study type Interventional
Source University Hospital, Caen
Contact
Status Recruiting
Phase N/A
Start date January 2, 2018
Completion date January 2024

See also
  Status Clinical Trial Phase
Completed NCT03155139 - Primary Aldosteronism In Hypertensive Patients in China
Withdrawn NCT04556279 - Investigating Salt Taste Threshold in Patients Being Investigated for Primary Hyperaldosteronism Before and After Treatment.